Skip to main content

Year: 2023

Atlantica Reports Third Quarter 2023 Financial Results

Revenue and Adjusted EBITDA for the first nine months of 2023 remained stable at $858.6 million and $627.3 million, respectively, compared to $858.4 million and $630.6 million in the nine months of 2022. Net profit for the first nine months of 2023 attributable to the Company was $46.1 million, compared with a net loss of $9.5 million in the first nine months of 2022. Cash available for distribution (“CAFD”) in the first nine months of 2023 was $184.2 million, an increase of 0.6% on a comparable basis1 (2.9% growth year-over-year). Quarterly dividend of $0.445 per share approved by the Board of Directors. Strategic Review ongoing.November 8, 2023 – Atlantica Sustainable Infrastructure plc (NASDAQ: AY) (“Atlantica” or the “Company”) today reported its financial results for the first nine months of 2023. Revenue and Adjusted EBITDA...

Continue reading

Kornit Digital Reports Third Quarter 2023 Results

Third quarter revenues of $59.2 million, in line with previous guidance Third quarter GAAP net loss of $8.2 million; non-GAAP net loss of $3.4 million Impressions and consumables revenues both continued to grow year-over-year System sales increased quarter-over-quarter on continued conversion of ITMA orders Company operations have not been materially impacted by the security situation in IsraelROSH-HA’AYIN, Israel, Nov. 08, 2023 (GLOBE NEWSWIRE) — Kornit Digital Ltd. (“Kornit” or the “Company”) (Nasdaq: KRNT), a worldwide market leader in sustainable, on-demand, digital fashionX and textile production technologies, reported today its results for the third quarter ended September 30, 2023. “We delivered third quarter revenues within our guidance range, despite a challenging macroeconomic environment. Our consumables sales...

Continue reading

KP Tissue Releases Third Quarter 2023 Financial Results

Volume and margin recovery driving strong Adjusted EBITDA MISSISSAUGA, Ontario, Nov. 08, 2023 (GLOBE NEWSWIRE) — KP Tissue Inc. (KPT) (TSX: KPT) reports the Q3 2023 financial and operational results of KPT and Kruger Products Inc. (Kruger Products). Kruger Products is Canada’s leading manufacturer of quality tissue products for the Consumer market (Cashmere®, Purex®, SpongeTowels®, Scotties®, White Swan® and BonterraTM) and the Away-From-Home (AFH) market and continues to grow in the U.S. Consumer tissue business with the White Cloud® brand and premium private label products. KPT currently holds a 13.1% interest in Kruger Products. Kruger Products Q3 2023 Business and Financial HighlightsRevenue was $473.4 million in Q3 2023 compared to $427.0 million in Q3 2022, an increase of $46.4 million or 10.9%. Adjusted EBITDA1 was...

Continue reading

Kandi Technologies Reports Third Quarter 2023 Financial Results

– Product Transformation Initiative Driving Profit Growth – Nine-month Net Income of $6.3 Million, Diluted EPS of $0.08 JINHUA, China, Nov. 08, 2023 (GLOBE NEWSWIRE) — Kandi Technologies Group, Inc. (the “Company”, “we” or “Kandi”) (NASDAQ GS: KNDI), today announced its financial results for the third quarter of 2023. Third Quarter and Nine Months 2023 Financial Highlights Third quarter total revenues of $36.4 million increased by 8.2% year-over-year.Nine-month revenues of $95.2 million increased by 19.9% year-over-year. Net income for the nine months was $6.3 million, or $0.08 income per fully diluted share, compared to a net loss of $2.4 million, or $0.03 loss per fully diluted share for the same period of 2022. Cash and cash equivalents, restricted cash, and certificate of deposit totaled $244.5 million as of September...

Continue reading

MasterCraft Boat Holdings, Inc. Reports Results for Fiscal 2024 First Quarter

VONORE, Tenn., Nov. 08, 2023 (GLOBE NEWSWIRE) — MasterCraft Boat Holdings, Inc. (NASDAQ: MCFT) today announced financial results for its fiscal 2024 first quarter ended October 1, 2023. Highlights: Unless otherwise indicated, the highlights and commentary provided herein relate to our continuing operations, which excludes our former NauticStar segment. Results for NauticStar are reported as discontinued operations.Net sales for the first quarter decreased to $104.2 million, down 38.5% from the prior-year period. Net income from continuing operations was $7.1 million, or $0.41 per diluted share. Diluted Adjusted Net Income per share, a non-GAAP measure, was $0.47, down 67.1%. Adjusted EBITDA, a non-GAAP measure, decreased to $12.2 million, down 66.0%. Share repurchases of $5.8 million during the quarter. Ended the quarter with...

Continue reading

Investigator Sponsor of HCW Biologics’ Phase 1 Clinical Trial Presented Human Data Readout and Anti-Cancer Mechanism of Action of HCW9218 at 38th SITC Annual Meeting

Showed HCW9218 clinical safety and tumor response endpointsfor 15 patients with heavily pretreated advanced solid tumors Results in ovarian cancer patients outpace other indications, with 66% stable disease MIRAMAR, Fla., Nov. 08, 2023 (GLOBE NEWSWIRE) — HCW Biologics Inc. (the “Company” or “HCW Biologics”) (NASDAQ: HCWB), a clinical-stage biopharmaceutical company focused on discovering and developing novel immunotherapies to lengthen healthspan by disrupting the link between inflammation and age-related diseases, announced results from a preliminary human data readout from an ongoing Phase 1 clinical trial sponsored by the University of Minnesota to evaluate HCW9218, the lead drug candidate of HCW Biologics, in patients with solid tumors who failed at least two prior lines of therapy. Data from this study was presented at the...

Continue reading

NuVista Energy Ltd. Announces Record Quarterly Production and Positive Third Quarter 2023 Financial and Operating Results and Provides 2024 Guidance

CALGARY, Alberta, Nov. 08, 2023 (GLOBE NEWSWIRE) — NuVista Energy Ltd. (“NuVista” or the “Company”) (TSX:NVA) is pleased to announce strong financial and operating results for the three and nine months ending September 30, 2023. We continued to invest in a disciplined manner in new high-return wells to fill and optimize existing facilities. New well production results continue to meet and exceed expectations, driving our production to new highs. At the same time as achieving record production, we made significant progress in returning capital to shareholders under our existing Normal Course Issuer Bid (the “2023 NCIB”) while continuing to reduce debt. Third Quarter 2023 Operational and Financial Highlights During the third quarter of 2023, NuVista:Produced a record average of 80,382 Boe/d, meeting our guidance expectations and...

Continue reading

Stock Yards Bancorp to Participate in the Piper Sandler 2023 East Coast Financial Services Conference

LOUISVILLE, Ky., Nov. 08, 2023 (GLOBE NEWSWIRE) — Stock Yards Bancorp, Inc. (NASDAQ: SYBT), parent company of Stock Yards Bank & Trust Company, with offices in Louisville, central, eastern and northern Kentucky, as well as the Indianapolis, Indiana and Cincinnati, Ohio metropolitan markets, today announced that Ja Hillebrand, Chairman and CEO and T. Clay Stinnett, EVP and CFO will participate in the Piper Sandler 2023 East Coast Financial Services Conference to be held November 15th and 16th, and will participate in a series of meetings with institutional investors. Management’s discussion materials to be used at this conference will be posted to the investor section of the Company’s website, www.syb.com, on or before November 15, 2023. Louisville, Kentucky-based Stock Yards Bancorp, Inc., with $7.9 billion in assets, was...

Continue reading

Applied UV’s Subsidiary, Sterilumen, Launches New Air and HVAC Disinfection Solutions at the Dubai Gulfood Manufacturing Trade Show

NEW YORK, NY, Nov. 08, 2023 (GLOBE NEWSWIRE) — via NewMediaWire – Applied UV, Inc. (NASDAQ: AUVI), a leader in global food security, air quality, and intelligent building solutions, today announced its participation at the Gulfood Manufacturing event underway in Dubai, November 7-9. This event is the preeminent food security trade show in the region, and Sterilumen is exhibiting along with its partner, Batta Environmental (https://battaenv.com/global/). The event brings together top-tier players in the food preservation and safety sector, providing a robust platform for the unveiling of ground-breaking technologies that address the region’s unique climate related challenges. Sterilumen has unveiled two new pioneering solutions aimed at revolutionizing food safety and preservation standards in the region during the event: The...

Continue reading

Arbutus to Present at Jefferies London Healthcare Conference

WARMINSTER, Pa., Nov. 08, 2023 (GLOBE NEWSWIRE) — Arbutus Biopharma Corporation (Nasdaq: ABUS) (“Arbutus” or the “Company”), a clinical-stage biopharmaceutical company leveraging its extensive virology expertise to develop a cure for people with chronic hepatitis B virus (cHBV) infection, today announced that the Arbutus management team will participate in and host one-on-one meetings at the following investor conference: Jefferies London Healthcare Conference: Formal presentation on Wednesday, November 15, 2023 at 11:30 am GMT / 6:30 am EDT. To access the live webcast of the presentation please visit: https://investor.arbutusbio.com/events-presentations. An archived replay of the webcast will be available on the Arbutus website for a limited time after the event. About Arbutus Arbutus Biopharma Corporation (Nasdaq: ABUS) is a...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.